Listen

Add to my selection

SIRTURO

Medicine - Posted on Oct 02 2025

Active substance (DCI)

bedaquiline

history (3)

9/10/25

SIRTURO (bédaquiline) - Tuberculose pulmonaire multirésistante chez l'adulte et l'enfant de plus de 5 ans

Extension d’indication / Inscription L'essentiel Avis favorable au remboursement dans le cadre d’une association appropriée ...

CAV :
54321

icône flèche
9/9/20

SIRTURO

Key points Favourable opinion for reimbursement in the indication extension “treatment of pulmonary multidrug-resistant tube...

CAV :
54321

icône flèche
7/22/15

SIRTURO (bedaquiline), antituberculosis agent

Moderate improvement in combination with other antituberculosis agents in the treatment of multidrug resistant pulmonary tub...

CAV :
54321

icône flèche

Technical information

ATC code

J04AK05

Manufacturer

JANSSEN-CILAG

Presentation

SIRTURO 100 mg comprimé
4 plaquette(s) thermoformée(s) aluminium de 6 comprimé(s) (CIP : 34009 300 158 1 0)

All our publications

Pulmonary and pleural diseases